Skin Cancer | Tumor

Hairdressers Could be Key in Identifying Scalp and Neck Melanomas

December 27th 2017

A group of researchers are working to determine whether more of these melanomas would be detected, and diagnosed earlier, if hairdressers were taught to recognize them.

Identifying Safe Windows for Melanoma Surgery Improves Survival

December 27th 2017

A study published in the Journal of the American Academy of Dermatology evaluated the impact of time between melanoma diagnosis and surgery on the survival of people with stage 1 to stage 3 cutaneous melanoma.

The Season of Grief, Gratitude and Compassion

December 23rd 2017

Of course, there was sadness, but more than anything there was appreciation for my own life and the people close to me. I feel gratitude for still being here, having an excellent quality of life and for the warning cancer gives.

Tafinlar Plus Mekinist Combination Granted Priority Review for Melanoma Treatment

December 22nd 2017

The Food and Drug Administration (FDA) has granted a priority review to a supplemental new drug application (sNDA) for the use of Tafinlar (dabrafenib) combined with Mekinist (trametinib) as an adjuvant treatment for patients with BRAFV600E– or V600K–positive stage 3 melanoma following complete resection.

Another "C" Word Is Cope: Coping Strategies for the Holidays

December 21st 2017

Breast cancer and melanoma survivor shares coping strategies for the holidays.

FDA Approves Adjuvant Opdivo for Melanoma Treatment

December 21st 2017

The FDA has approved Opdivo (nivolumab) as an adjuvant treatment for patients with completely resected melanoma with lymph node involvement or metastatic disease, based on findings from the phase 3 CheckMate-238 trial.

A Smile Could Mean the World to Someone With Cancer

November 15th 2017

Jim Kelly, NFL Hall of Famer, discusses how much a smile or a kind word can mean to someone with cancer – and he knows from experience.

Genetic Counseling and Testing Can Be Tough to Revisit

November 14th 2017

It was a hard call to make. It felt like choosing to step into the mud—again. Revisit cancer? Seriously? Why?

In Memoriam: Jen Sotham

November 14th 2017

One of our valued community members, Jen Sotham, passed away on Nov. 9. Jen was diagnosed with metastatic melanoma in 2014, but that did not prevent her from living out her dreams and having her voice heard through film, blogging, a TED talk and contributing to CURE® — both in print and on the web.

Immunotherapy Combination Improves Melanoma Outcomes, But at a Cost

November 13th 2017

Treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) improved response rates in patients with melanoma, but not without some severe side effects.

Managing Advanced Lung Cancer in the Future

November 13th 2017

Treatment Challenges in Advanced Lung Cancer

November 13th 2017

Side Effect Management in Advanced Lung Cancer

November 13th 2017

Promising Cancer Therapies in Advanced Lung Cancer

November 13th 2017

Palliative Care in Advanced Lung Cancer

November 13th 2017

Missing Mom

November 13th 2017

Two-time cancer survivor struggles with a different loss than cancer this holiday season.

Don't Let Cancer Ransom the Joy of the Holiday Season

November 11th 2017

Are you trying to get ready for the holidays in addition to being newly diagnosed with cancer, receiving active treatment or coping with survivorship? It’s not an easy task.

10 Diet and Exercise Tips for People Who Say, 'I Can't'

November 10th 2017

A two-time cancer survivor shares strategies that have helped her over the years with healthy eating habits and movement.

Combination Continues to Show Impressive Outcomes in Melanoma

November 3rd 2017

In an interview with CURE, Postow, a medical oncologist specializing in melanoma at Memorial Sloan Kettering Cancer Center, discussed the impressive efficacy seen with combining BRAF and MEK inhibitors for patients with melanoma.

Despite Laws Limiting Minors, Indoor Tanning Salons Not 100 Compliant

November 2nd 2017

Nearly a third of tanning salons surveyed were not compliant with their state laws.

Solving a Mystery to Fight a Rare Cancer

October 25th 2017

An immunotherapy finally gives doctors an approved weapon to fight Merkel cell carcinoma, a rare and still mysterious skin cancer.

New Normal: Life Before And After Cancer

October 24th 2017

It isn't always so "normal," is it?

Drug Combination Granted FDA Breakthrough Designation for Melanoma Treatment

October 23rd 2017

The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) for the adjuvant treatment of patients who have stage 3 melanoma and a BRAF V600 mutation, after they have already had a complete resection.

Novel Therapy Combinations Are Needed for Melanoma Treatment

October 23rd 2017

Research into combination approaches now focuses on using three anti–PD-1 therapies and new checkpoints, such as IDO.

Immunotherapy Combination Sparks a Response in Melanoma Brain Metastases

October 23rd 2017

The combination of the immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) sparked a response in nearly half of asymptomatic patients with melanoma brain metastases who had not received prior local therapy to the brain.

New Immunotherapy Shows Response for Metastatic Melanoma, Study Says

October 23rd 2017

The longest response rate lasted six months.

Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma

October 20th 2017

Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.

Associating Genes With Melanoma Risk

October 19th 2017

Maria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.

Intralesional Combinations Are Promising in Melanoma

October 19th 2017

Intralesional therapies – those delivered directly to the tumor site – used in conjunction with checkpoint inhibitors have shown improvements to the treatment of people with melanoma, says Robert Andtbacka, M.D., in a presentation at the 2017 World Congress of Melanoma.

Care to Comment on Draft USPSTF Statement on Sun Protection?

October 19th 2017

Members of the public can submit comments to the U.S. Preventive Services Task Force (USPSTF) on its draft recommendation statement on sun protection until Nov. 6, 2017.